On the other hand, the expression of GPI-APs, such as carcinoembryonic antigen (CEA)19, mesothelin20, folate receptor21, glypican-322, and CD5223 is upregulated in various cancer cells, and such GPI-APs are utilized as biomarkers and therapeutic targets. Here, CEACAM5 is linked to cancer.